These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17103172)

  • 21. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S).
    Zochling J
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S47-58. PubMed ID: 22588768
    [No Abstract]   [Full Text] [Related]  

  • 22. Translation and validation of the Chinese Social Role Participation Questionnaire in patients with ankylosing spondylitis.
    Zhang G; Li J; Liu D; Wang T; Wang Y; Xu W
    Clin Rheumatol; 2018 Mar; 37(3):655-660. PubMed ID: 29151172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a combination treatment of an intensive rehabilitation program and etanercept in patients with ankylosing spondylitis: a pilot study.
    Lubrano E; D'Angelo S; Parsons WJ; Serino F; Tanzillo AT; Olivieri I; Pappone N
    J Rheumatol; 2006 Oct; 33(10):2029-34. PubMed ID: 17014018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis.
    van der Heijde DM; Revicki DA; Gooch KL; Wong RL; Kupper H; Harnam N; Thompson C; Sieper J;
    Arthritis Res Ther; 2009; 11(4):R124. PubMed ID: 19686597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
    Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
    Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis].
    Salaffi F; Stancati A; Silvestri A; Carotti M; Grassi W
    Reumatismo; 2005; 57(3):161-73. PubMed ID: 16258600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
    Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life and correlation with clinical and radiographic variables in patients with ankylosing spondylitis: a retrospective case series study.
    Huang JC; Qian BP; Qiu Y; Wang B; Yu Y; Zhu ZZ; Hu J; Qu Z
    BMC Musculoskelet Disord; 2017 Aug; 18(1):352. PubMed ID: 28810915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis.
    Rudwaleit M; Listing J; Brandt J; Braun J; Sieper J
    Ann Rheum Dis; 2004 Jun; 63(6):665-70. PubMed ID: 15037444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register.
    Lord PA; Farragher TM; Lunt M; Watson KD; Symmons DP; Hyrich KL;
    Rheumatology (Oxford); 2010 Mar; 49(3):563-70. PubMed ID: 20032223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiological progression and life quality analysis in ankylosing spondylitis patients using etanercept/methotrexate combination therapy].
    Wang Y; Lian F; Li JP; Chen W; Yang XY; Yang NS; Yang JY; Meng QF
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(15):1022-5. PubMed ID: 21609635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous efficacy of etanercept in severe and advanced ankylosing spondylitis: results from a 12-week open-label extension of the SPINE study.
    Dougados M; Braun J; Szanto S; Combe B; Geher P; Leblanc V; Logeart I
    Rheumatology (Oxford); 2012 Sep; 51(9):1687-96. PubMed ID: 22653382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis.
    Bidad K; Fallahi S; Mahmoudi M; Jamshidi A; Farhadi E; Meysamie A; Nicknam MH
    Rheumatol Int; 2012 Nov; 32(11):3613-8. PubMed ID: 22101612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient reported outcomes in ankylosing spondylitis: development and validation of a new questionnaire for functional impairment and quality of life assessment.
    El Miedany Y; El Gaafary M; El Aroussy N; Ahmed I; Youssef S; Palmer D
    Clin Exp Rheumatol; 2011; 29(5):801-10. PubMed ID: 22011622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of etanercept for treating ankylosing spondylitis].
    Liang LQ; Zhan ZP; Ye YJ; Fu D; Xu HS; Yang XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1349-51. PubMed ID: 18753057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.
    Woo JH; Lee HJ; Sung IH; Kim TH
    J Rheumatol; 2007 Aug; 34(8):1753-9. PubMed ID: 17610317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis.
    Calin A; Dijkmans BA; Emery P; Hakala M; Kalden J; Leirisalo-Repo M; Mola EM; Salvarani C; Sanmartí R; Sany J; Sibilia J; Sieper J; van der Linden S; Veys E; Appel AM; Fatenejad S
    Ann Rheum Dis; 2004 Dec; 63(12):1594-600. PubMed ID: 15345498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    Gorman JD; Sack KE; Davis JC
    N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.
    Baraliakos X; Brandt J; Listing J; Haibel H; Sörensen H; Rudwaleit M; Sieper J; Braun J
    Arthritis Rheum; 2005 Dec; 53(6):856-63. PubMed ID: 16342093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translation, cultural adaptation, and validation of the Bath questionnaires and HAQ-S in Hindi for Indian patients with ankylosing spondylitis.
    Dhir V; Kulkarni S; Adgaonkar A; Dhobe P; Aggarwal A
    Clin Rheumatol; 2012 Oct; 31(10):1511-5. PubMed ID: 22829065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.